Literature DB >> 12139942

Rheumatoid factors: host resistance or autoimmunity?

Marianna M Newkirk1.   

Abstract

Rheumatoid factors (RFs), autoantibodies that bind to the Fc portion of IgG, are important in the immune response. RF-committed B-cells exist in the circulating lymphocyte pool in a high frequency (approximately 1-2 %) in normal individuals and in patients with pathological conditions associated with the sustained levels of circulating RF, such as rheumatoid arthritis (RA), Sjogren's syndrome (SS), and mixed cryoglobulinemia, associated with hepatitis C virus infection. RFs are induced by many infectious entities (viruses, bacteria, parasites) as a consequence of a secondary immune response to the pathogen, but usually the response is transient. It is likely that RFs play an important role in the host's defense against infection, both at the cellular level, where the RF B-cell can be an antigen presenting cell which can promote the antipathogen response, and at the humoral level, where RFs can contribute to the mopping up of the IgG antipathogen antibodies by contributing to immune complex formation and clearance. There has been much research on RFs in chronic pathological conditions, and the literature pertaining to their origin, structure, binding specificities, and possible roles in disease are discussed. The importance of the host defense, sometimes at the expense of an autoimmune response, is a balance that needs to be considered in light of a possible outcome of health or disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139942     DOI: 10.1006/clim.2002.5210

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  38 in total

Review 1.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Rheumatoid factor induction in murine models of liver injury.

Authors:  U Nowak; K Gill; E Skamene; M M Newkirk
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

3.  Agonistic antibodies to Fas induce a breach in the endothelial lining of the liver and a breakdown in B cell tolerance.

Authors:  M M Newkirk; U Nowak; E Skamene; D Iera; J Desbarats
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

4.  Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages.

Authors:  Ziyan Yang; David M Mosser; Xia Zhang
Journal:  J Immunol       Date:  2007-01-15       Impact factor: 5.422

Review 5.  B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Discovery and characterization of a peptide motif that specifically recognizes a non-native conformation of human IgG induced by acidic pH conditions.

Authors:  Kotaro Sakamoto; Yuji Ito; Takaaki Hatanaka; Preeti Brijiral Soni; Toshiyuki Mori; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

7.  Usefulness of rheumatoid factor as an immunological and prognostic marker in PSS patients.

Authors:  Maria Maślińska; Małgorzata Mańczak; Brygida Kwiatkowska
Journal:  Clin Rheumatol       Date:  2019-02-27       Impact factor: 2.980

8.  Testing for Rheumatological Diagnoses in Children.

Authors:  Judith A Smith
Journal:  Eur Paediatr Rev       Date:  2009

9.  Immunoglobulin G structure and rheumatoid factor epitopes.

Authors:  Sheila Lefoli Maibom-Thomsen; Nicole Hartwig Trier; Bettina Eide Holm; Kirsten Beth Hansen; Morten Ib Rasmussen; Anna Chailyan; Paolo Marcatili; Peter Højrup; Gunnar Houen
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

Review 10.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.